Presence Marketing talks CBD and hemp: 'We need a few things to happen before CBD can realize its destiny'

By Mary Ellen Shoup contact

- Last updated on GMT

©GettyImages / Aleksandr_Kravtsov
©GettyImages / Aleksandr_Kravtsov

Related tags: Cbd, Hemp, Presence Marketing, FamilyFarmed

Presence Marketing, the largest independent natural and organic food broker in the US, sees CBD as a massive "bankable trend" for the broader CPG industry with products such as tinctures and supplements - which consumers perceive to be more 'potent' - driving most of the growth in the near term.

Presenting at FamilyFarmed's Good Food Financing & Innovation Conference​, vice president of innovation and brand development at Presence marketing, Tracy Miedema, shared that approximately 75% of US CBD commerce will come from products consumers believe to be more potent such as tinctures and supplements.

Functional ingredient sales growth of CBD through US retail outlets (excluding Whole Foods) reached $185.1m in the 52-week period ended Aug. 11, more than triple the $47.2 million in the previous 52-week period, according to SPINS data. Roughly 60% of CBD product sold in the US natural channel in 2018 were in the form of alcohol-free tinctures, followed by capsules and softgels. 

"Sales of CBD as a supplement have just exceeded turmeric​ in the last six weeks or so,"​ said Miedema, who noted the parallel between turmeric's draw as an adaptogenic ingredient when it first gained traction in the market. 

"We’re also really excited about snacks and beverages, but in the long run, what people are looking for is that potency. And so, delivery systems that go right to the heart of what consumers are seeking we still believe will be the big drivers of commerce,"​ she said. 

Consumers report anxiety, sleep, and pain relief as top purchase motivators

While food and beverage brands are not permitted to make any health claims around CBD, many consumers are drawing their own conclusions about the ingredient's functional benefits.

According to Miedema, the top three health benefits consumers report as being their primary purchase drivers for products containing CBD revolve around anxiety, sleep, and pain management. 

"Those are the big three ​[health benefits consumers associate with CBD], but there's a vast array of conditions consumers are reporting,"​ she said.

Brands such as Recess sparkling water, which includes on-pack language stating that it it uses hemp extracts and adaptogens, previously told FoodNavigator-USA that it is marketing a feeling​ ('calm cool collected') rather than an an ingredient. 

Hemp-based foods, an adjacent second wind of growth?

As consumers' understanding of CBD and hemp-derived CBD grows, hemp-based (particularly hemp seeds which do not contain CBD) foods are seeing an uplift in sales as result, according to Presence Marketing. 

"We also see some really wonderful 'bankability' and kind of a second wind for hemp-based foods,"​ Miedema said. 

Humming Hemp​, for instance, which makes protein bars made from hemp seeds, has experienced strong retail growth striking nationwide distribution deal with Kroger this year.

"Predominantly industrial hemp is being grown for CBD and the seeds are a byproduct. We’re able to take the hemp seeds to market as a protein superfood," ​​Kelsay previously told FoodNavigator-USA. 

'We need a few things to happen before CBD can realize its destiny'

While many in the industry might regard the passage of the 2018 Farm Bill as a 'watershed' moment for the hemp-derived CBD market, the regulatory reality is that the FDA has clearly stated that CBD is illegal to use as a food, beverage, and dietary supplement ingredient. 

"Thank goodness we now have this bright red line from a regulatory standpoint that now puts hemp on one side, and puts marijuana on the other side,"​ said Miedema. 

"In the really long term, we think the line is going to be drawn more around intoxication because it turns out you can have a higher THC content than 0.3% and not be intoxicated," ​she claimed. "And a lot of us who are cannabis plant devotees think that percentage can be higher to really get that adaptogenic effect that the human body craves."

However, the next wave of growth for hemp-derived CBD won't be truly unleashed until the industry receives further guidance from the FDA, which is when Miedema predicts demand (especially from conventional retailers and big food manufacturers) will skyrocket. 

"We need a few things to happen before CBD can realize its destiny,"​ Miedema added. 

Related news

Related products

show more

Product Recovery (Pigging) for Food Manufacturers

Product Recovery (Pigging) for Food Manufacturers

HPS Product Recovery Solutions | 25-Nov-2019 | Technical / White Paper

Sanitary product recovery ("pigging") is in wide use by food manufacturers that pump liquids or wet products.
It gives a high ROI and...

Celery Juice and the Health-Conscious Consumer

Celery Juice and the Health-Conscious Consumer

Florida Food Products | 25-Oct-2019 | Technical / White Paper

Celery juice is an on-trend beverage ingredient with sought-after health benefits. Given its popularity, it’s no surprise that celery juice is showing...

Create plant-based products that consumers prefer

Create plant-based products that consumers prefer

Archer Daniels Midland Company | 21-Oct-2019 | Technical / White Paper

It takes more than just knowing what protein options exist to create irresistible, consumer-preferred foods. As products starring plant-based proteins...

Related suppliers

1 comment

A few things to happen before "CBD" achieves validity

Posted by Anthony L. Almada, MSc, FISSN,

Painfully absent from this piece is acknowledgement that, to date, no systematic studies in humans have shown CBD-centric extracts of hemp to have any effect related to impaired sleep quality, mood/anxiety, and (especially) pain relief. Moreover, no mention that all of the claims that are attributed to "CBD" center upon compositions that are NOT available in commerce. No articles have appeared on foodnavigator.com identifying and dimensionalizing the voluminous gap between the exhorted benefits and mechanisms (e.g. "entourage effect" in the absence of ∆9-THC) and the actual evidence. Indeed, the two published studies to date (one being randomized/controlled) found ZERO impact of CBD upon pain. Isn't it time for some strong, investigative journalism that is not subservient to advertiser interests?

Report abuse

Post your comment

We will not publish your email address on the website

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Follow us

Featured Events

View more

Products

View more

Webinars